PD-L1 and Emerging Biomarkers in Immune Checkpoint Blockade Therapy.

Cottrell, Tricia R

PD-L1 and Emerging Biomarkers in Immune Checkpoint Blockade Therapy. [electronic resource] - Cancer journal (Sudbury, Mass.) - 41-46 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

1540-336X

10.1097/PPO.0000000000000301 doi


Biomarkers, Tumor--antagonists & inhibitors
Humans
Lymphocytes, Tumor-Infiltrating--drug effects
Mutation--drug effects
Neoplasms--genetics
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Tumor Burden--drug effects
Tumor Microenvironment--drug effects